What is the treatment for elevated androgen (hyperandrogenism) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Hyperandrogenism

The first-line treatment for hyperandrogenism is anti-androgen therapy with spironolactone, combined with lifestyle modifications if applicable, while avoiding exogenous testosterone therapy which would worsen the condition. 1

Diagnostic Evaluation

Before initiating treatment, a proper diagnostic workup is essential to identify the underlying cause:

  • Laboratory assessment:

    • Total and free testosterone levels
    • DHEA-S levels (to assess adrenal androgen production)
    • 17-hydroxyprogesterone (to evaluate for non-classical congenital adrenal hyperplasia)
    • LH/FSH ratio (>2 suggests PCOS)
    • Morning cortisol and ACTH levels 1, 2
  • Imaging studies:

    • Adrenal CT or MRI if adrenal tumor is suspected
    • Pelvic ultrasound if PCOS is suspected 1

Treatment Algorithm

1. Determine the Source of Hyperandrogenism

For Ovarian Hyperandrogenism (e.g., PCOS):

  • First-line: Combined oral contraceptives (COCs) 3
    • Suppress ovarian androgen production
    • Increase sex hormone-binding globulin (SHBG)
    • Reduce free testosterone levels

For Adrenal Hyperandrogenism (e.g., Congenital Adrenal Hyperplasia):

  • First-line: Glucocorticoid replacement therapy 1
    • Hydrocortisone 15-20 mg daily in divided doses
    • Goal: Normalize androstenedione and other adrenal androgens

2. Anti-Androgen Therapy

  • Spironolactone: 25-100 mg daily, can be titrated up to 200 mg daily 4

    • Blocks androgen receptors
    • Has additional anti-androgenic effects by inhibiting androgen production
    • Monitor for hyperkalemia, especially in patients with renal impairment
  • Other options:

    • Cyproterone acetate (not available in US)
    • Flutamide (limited use due to hepatotoxicity) 5

3. Adjunctive Measures

  • Avoid medications that worsen hyperandrogenism:

    • ACE inhibitors 3
    • Exogenous testosterone 1
  • Lifestyle modifications:

    • Weight loss if overweight/obese
    • Regular exercise
    • Stress reduction 3, 1

Special Considerations

Pregnancy

  • Androgens are contraindicated during pregnancy due to risk of fetal virilization
  • For women planning pregnancy, discuss alternative treatments 3

Postmenopausal Women

  • Rule out androgen-producing tumors, which are more common in this population
  • Consider MRI of adrenal glands or ovaries if testosterone levels are markedly elevated 6

Monitoring and Follow-up

  • Clinical assessment every 3-6 months:

    • Signs of androgen excess (hirsutism, acne, menstrual irregularities)
    • Signs of treatment side effects
  • Laboratory monitoring:

    • Hormone measurements (androstenedione, 17-hydroxyprogesterone) every 3-6 months
    • Potassium levels if on spironolactone 1, 4

Common Pitfalls to Avoid

  1. Delayed treatment: Treatment of acne and hirsutism should not be withheld during ongoing evaluation for possible PCOS 2

  2. Unrealistic expectations: Improvement in clinical symptoms (especially hirsutism) may take 6-12 months; patients should be counseled accordingly 7

  3. Inadequate monitoring: Failure to monitor for side effects of medications, particularly hyperkalemia with spironolactone 4

  4. Overlooking serious causes: Rapid onset of virilization may indicate an androgen-producing tumor requiring urgent evaluation 5, 6

  5. Discontinuing treatment prematurely: Anti-androgen therapy typically needs to be continued long-term, as symptoms often recur when treatment is stopped 7

By following this structured approach, hyperandrogenism can be effectively managed, leading to improvement in both physical symptoms and quality of life.

References

Guideline

Hormone Panel Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hyperandrogenism, adrenal dysfunction, and hirsutism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2020

Research

Postmenopausal hyperandrogenism.

Climacteric : the journal of the International Menopause Society, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.